LABD 股價展望與 ETF 分析 - 配息·管理費·持股·NAV·RSI·MACD

LABD

Direxion Daily S&P Biotech Bear 3X ETF

收盤價 10月26日 4:00 PM ET（韓國 10/27 05:00）

$7.81

-0.15 ▼ -1.88%

10月27日 5:14 AM ET（韓國 10/27 18:14）

$7.79

-0.02 ▼ -0.26%

下降通道阻力線 8.32 支撐線 4.39 維持由 AI 繪製的參考線，可能有誤，僅供參考，並非預測。

詳細指標表

Category ⓘ	Equity - Leveraged / Inverse	Expense ⓘ	1.07%	Return% 1Y ⓘ	-74.78%	Total Holdings ⓘ	11	Perf Week ⓘ	-5.79%	Volume ⓘ	12,312,405
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$79M	Return% 3Y ⓘ	-66.93%	NAV ⓘ	$7.95	Perf Month ⓘ	5.26%	Avg Volume ⓘ	19.65M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	$0.46 (5.89%)	Return% 5Y ⓘ	-46.75%	52W High ⓘ	-76.5%	Perf Quarter ⓘ	-12.35%	Rel Volume ⓘ	0.63
Active/Passive ⓘ	Passive	Div Gr. 3/5Y ⓘ	15.24% -32.4%	Return% 10Y ⓘ	-56.92%	52W Low ⓘ	34.42%	Perf Half Y ⓘ	-45.19%	Prev Close ⓘ	$7.96
IPO ⓘ	2015/5/28	Flows% 1M ⓘ	-50.4%	Return% SI ⓘ	-54.81%	RSI (14) ⓘ	50.8	Perf YTD ⓘ	-62.92%	Price ⓘ	$7.81
Beta ⓘ	-2.52	Flows% 3M ⓘ	-13.18%	Flows% YTD ⓘ	143.29%	Flows% 1Y ⓘ	847.88%	Perf Year ⓘ	-75.39%	Volatility(W/M) ⓘ	8.19% 8.49%
SMA20 ⓘ	-0.41%	SMA50 ⓘ	7.96%	SMA200 ⓘ	-37.67%	ATR ⓘ	0.65

ETF 簡介

Direxion Daily S&P Biotech Bear 3X ETFLABD | NYSE | 反向型查看深度分析

Direxion Daily S&P Biotech Bear 3X Shares seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests at least 80% of its net assets (plus borrowing for investment purposes) in swap agreements, futures contracts, short positions or other financial instruments that provide inverse (opposite) or short daily exposure to the index or to ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.

注意

與指數 反向 3 倍波動

長期持有會不斷損耗價值。它是為一兩天的短線交易設計的商品。

LABD ETF 一覽

1.07% 越低越好

$79M 管理資產

11檔

5.89% 季配

掛牌日 2015年

管理方式追蹤指數

發行公司 Direxion

主要持有標的持有 11 檔